A Study of EDP-514 in Healthy Subjects (Part 1) and Patients With Chronic Hepatitis B Virus Infection (Part 2)

Clinical trial NCT04008004 · COMPLETED

Trial details

NCT number: NCT04008004
Sponsor: Enanta Pharmaceuticals, Inc
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic HBV Infection

Start date: 2019-06-26
Primary completion: 2021-07-14
Enrollment: 99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.